Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients with History of Prior Stroke Plus Diabetes

BACKGROUND AND PURPOSE: Acute ischemic stroke (AIS) patients with history of prior ischemic stroke plus concomitant diabetes mellitus (DM) were excluded from the ECASS III trial due to safety concerns. However, there are few data on use of intravenous tissue plasminogen activator (tPA) and symptomat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stroke
Autori principali: Ehrlich, Matthew E., Liang, Li, Xu, Haolin, Kosinski, Andrzej S., Hernandez, Adrian F., Schwamm, Lee H., Smith, Eric E., Fonarow, Gregg C., Bhatt, Deepak L., Peterson, Eric D., Xian, Ying
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6538420/
https://ncbi.nlm.nih.gov/pubmed/31035901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.024172
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi